These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9651604

  • 1. [Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections].
    Shinagawa N, Takeda S, Oohira S, Yasuda Y, Fujisaki M, Saito H, Ueda M, Mitamura K, Nishio T, Itakura M, Koyama M, Hirano M, Ohyama R, Kako M, Amako Y, Okuda K, Iwasa T, Sugiyama A, Hirano M, Takashima S, Ohswawa N, Nakaya S, Yamada M, Zeze F, Ishii J.
    Jpn J Antibiot; 1997 Nov; 50(11):862-70. PubMed ID: 9651604
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T, Takamoto M, Shinoda A, Yoshida M, Ichikawa Y, Kido M, Ninomiya K, Kitahara Y, Hara N, Tsurutani H.
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M, Inoue T, Morita Y, Ito K, Togano Y, Yamanaka K, Hirose S, Takahashi T, Mita S, Mano K.
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [Abstract] [Full Text] [Related]

  • 4. [Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
    Ohno R, Hotta T, Ogura M, Ohnishi K, Morishita T, Murate T, Okumura M, Tanimoto M, Inoue C, Hamaguchi M.
    Jpn J Antibiot; 1989 Aug; 42(8):1713-9. PubMed ID: 2810734
    [Abstract] [Full Text] [Related]

  • 5. [Studies on sulbactam/cefoperazone in the field of pediatrics].
    Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.
    Jpn J Antibiot; 1984 Oct; 37(10):1859-79. PubMed ID: 6094865
    [Abstract] [Full Text] [Related]

  • 6. [Clinical assessment of sulbactam/cefoperazone in comparison with ceftizoxime in patients with postoperative infections by well controlled method].
    Yura J, Shinagawa N, Ando M, Ishikawa S, Masaoka A, Kataoka M, Kondo T, Horisawa M, Suzuki H, Iriyama K.
    Jpn J Antibiot; 1985 Mar; 38(3):643-70. PubMed ID: 2993690
    [Abstract] [Full Text] [Related]

  • 7. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S, Tsuda S, Taniwaki M, Horiike S, Ariyama Y, Hirakawa K, Ueda Y, Kaneko H, Nakao M, Kashima K.
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [Abstract] [Full Text] [Related]

  • 8. [Effects of sulbactam/cefoperazone in patients with respiratory infections in aged and/or with underlying respiratory diseases].
    Akutsu I, Motojima S, Sagara H, Ogata H, Otsuka T, Fukuda T, Ikemori R, Makino S.
    Jpn J Antibiot; 1989 Apr; 42(4):910-20. PubMed ID: 2769942
    [Abstract] [Full Text] [Related]

  • 9. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Kitamura K, Takaku F, Miyazaki T, Miura, Mizoguchi H, Saito H, Masaoka T, Kimura I, Niho Y.
    Jpn J Antibiot; 1991 Sep; 44(9):979-86. PubMed ID: 1960859
    [Abstract] [Full Text] [Related]

  • 10. [Clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Obata I, Ryu F, Imagawa N, Ochiai K, Koike K, Morimoto O, Hachiya S.
    Jpn J Antibiot; 1984 Dec; 37(12):2478-94. PubMed ID: 6098741
    [Abstract] [Full Text] [Related]

  • 11. [Experience with sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Kohara T, Matsui Y, Noda M, Hirai S, Iida S.
    Jpn J Antibiot; 1984 Oct; 37(10):1934-8. PubMed ID: 6094872
    [Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology].
    Chimura T, Inoue K, Morisaki N.
    Jpn J Antibiot; 1984 Oct; 37(10):1928-33. PubMed ID: 6094871
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of sulbactam/cefoperazone in the pediatric infections].
    Meguro H, Tajima T, Nonaka C, Mashiko J, Fujii R, Arimasu O.
    Jpn J Antibiot; 1984 Oct; 37(10):1821-30. PubMed ID: 6094862
    [Abstract] [Full Text] [Related]

  • 14. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
    Uete T, Matsuo K.
    Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
    [Abstract] [Full Text] [Related]

  • 15. [Multicenter study of the effects of sulbactam/cefoperazone on bacterial infections in the fields of internal medicine focused mainly on respiratory infections in Tochigi Prefecture].
    Motojima S, Asakawa J, Ezure M, Tateishi K, Nakajima H, Hirata S, Sagara H, Arima M, Akutsu I, Fukuda T.
    Jpn J Antibiot; 1993 Oct; 46(10):918-25. PubMed ID: 8254894
    [Abstract] [Full Text] [Related]

  • 16. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
    Suzuki K, Horiba M.
    Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
    [Abstract] [Full Text] [Related]

  • 17. [Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)].
    Hirasawa S, Abe H, Bekki E, Hashimoto I, Sawada Y, Nakamura T, Mikami J, Watanabe Y.
    Jpn J Antibiot; 1980 Dec; 33(12):1294-300. PubMed ID: 6454012
    [Abstract] [Full Text] [Related]

  • 18. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A, Dhar P, Dharap S, Goel A, Gupta R, Hardikar JV, Kapoor VK, Mathur AK, Modi P, Narwaria M, Ramesh MK, Ramesh H, Sastry RA, Shah S, Virk S, Sudheer OV, Sreevathsa MR, Varshney S, Kochhar P, Somasundaram S, Desai C, Schou M.
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [Abstract] [Full Text] [Related]

  • 19. [Fundamental and clinical studies of sulbactam/cefoperazone in obstetrics and gynecology].
    Kubota K.
    Jpn J Antibiot; 1984 Nov; 37(11):2234-42. PubMed ID: 6098717
    [Abstract] [Full Text] [Related]

  • 20. [Fundamental and clinical studies on sulbactam/cefoperazone in the field of obstetrics and gynecology].
    Hirabayashi K, Okada E.
    Jpn J Antibiot; 1984 Nov; 37(11):2223-33. PubMed ID: 6098716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.